YALÇIN, Ş. Et Al. 2013. Bevacizumab + capecitabine as maintenance therapy after initial bevacizumab + XELOX treatment in previously untreated patients with metastatic colorectal cancer: Phase iii 'stop and go' study results - A turkish oncology group trial. Oncology (Switzerland) , vol.85, no.6 , 328-335.

YALÇIN, Ş., Uslu, R., Dane, F., Yilmaz, U., ZENGİN, N., Buyukunal, E., ... Buyukberber, S.(2013). Bevacizumab + capecitabine as maintenance therapy after initial bevacizumab + XELOX treatment in previously untreated patients with metastatic colorectal cancer: Phase iii 'stop and go' study results - A turkish oncology group trial. Oncology (Switzerland) , vol.85, no.6, 328-335.

YALÇIN, ŞUAYİB Et Al. "Bevacizumab + capecitabine as maintenance therapy after initial bevacizumab + XELOX treatment in previously untreated patients with metastatic colorectal cancer: Phase iii 'stop and go' study results - A turkish oncology group trial," Oncology (Switzerland) , vol.85, no.6, 328-335, 2013

YALÇIN, ŞUAYİB Et Al. "Bevacizumab + capecitabine as maintenance therapy after initial bevacizumab + XELOX treatment in previously untreated patients with metastatic colorectal cancer: Phase iii 'stop and go' study results - A turkish oncology group trial." Oncology (Switzerland) , vol.85, no.6, pp.328-335, 2013

YALÇIN, Ş. Et Al. (2013) . "Bevacizumab + capecitabine as maintenance therapy after initial bevacizumab + XELOX treatment in previously untreated patients with metastatic colorectal cancer: Phase iii 'stop and go' study results - A turkish oncology group trial." Oncology (Switzerland) , vol.85, no.6, pp.328-335.

@article{article, author={ŞUAYİB YALÇIN Et Al. }, title={Bevacizumab + capecitabine as maintenance therapy after initial bevacizumab + XELOX treatment in previously untreated patients with metastatic colorectal cancer: Phase iii 'stop and go' study results - A turkish oncology group trial}, journal={Oncology (Switzerland)}, year=2013, pages={328-335} }